Galvanize Therapeutics
Focus: Galvanize Therapeutics is a public biotech company specializing in bronchoscopic delivery of non-thermal pulsed electric fields (PEF) for oncology indications, particularly lung cancer. The company operates at scale with 5,000+ employees and is advancing its Aliya platform across multiple tumor types.
Profile data last refreshed 11h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
5000+
Open Jobs
8+8 this month
Growing — net +8 jobs in 30d
9 jobs added vs 1 removed. Steady team buildout.
Should You Work at Galvanize Therapeutics?
AI assessmentA recently FDA-validated device company with scale and public stability, but limited immediate hiring and an early-stage pipeline create uncertainty about career growth velocity and job availability.
Why Work Here
- Recently obtained FDA clearance for Aliya EX Generator (May 2026), validating the core platform and creating momentum for commercial expansion.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Pulsed electric field treatment using the Aliya system
Cancer of Lung, Kidney or LiverClinical Trials (1)
NCT04773275A Clinical Evaluation of the Aliya™ System in Late Stage Cancer
N/AHelp build intelligence for Galvanize Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.